BalkansCat/iStock Editorial via Getty Images
Estee Lauder (NYSE:EL) shares rose sharply on Wednesday as the company announced a plan to disclose “novel clinical and preclinical results that demonstrate scientific innovation and leadership across emerging areas of skin health and anti-aging” in July.
The consumer products and cosmetics company is set to present these innovations at the 25th World Congress of Dermatology in Singapore from July 3 to July 8. The research to be presented will pertain to 3 brands and will be shown during 5 separate presentations.
“We are thrilled to share key findings at the upcoming WCD from our most recent research efforts, which leverage insights from the fields of longevity and epigenetics to advance our understanding of the molecular pathways underlying inflammation and aging,” Dr. Nadine Pernodet, Senior Vice President for Bioscience, said. “The breadth and depth of data to be presented further reflects our robust combined R&D and clinical testing capabilities. These highly integrated areas of focus support our exploration of new ingredients or methodologies to ultimately help shape and advance the skin care landscape.”
The presentations will include data from studies on the effect of facial creams, the mechanobiology of the skin, a topical cosmetic serum with a “targeted, triple action approach [that] provides anti-aging benefits equal to or better than a single laser treatment”, and the benefits of moisturizer use.
Estee Lauder (EL) will also host a “Sirtuins and Longevity” symposium on July 6 that will feature “key research” on the relationship between sirtuins and their impact on skin.
“The new findings presented here will provide insight into how an understanding of aging pathways and targets will form the basis for skin longevity research, which will aid in the continued development of approaches to slow or reverse visible aging in skin,” the company said.
Shares of Estee Lauder (EL) rose 4.21% in afternoon trading on Wednesday.
